Tom has been a technology entrepreneur or, “never had a real job,” as his father always said, since he started his first company at the age of 23. He has been starting, growing and building businesses ever since. He has had some wonderful successes, some strikeouts, and some ventures that fell in between. He believes that he’s learned much more from his failures than from his successes along the way. He believes business is all about putting together the right team, setting goals, staying focused, and being fanatical about product design and customer service.
Marc Blumenthal is a serial entrepreneur and visionary leader in the technology industry, as well as an active investor and mentor in early-stage companies. Blumenthal acquired Intelladon in 2000, which he built from a small company to leading online learning provider and talent management service, and successfully sold the company to Tribridge in 2013. With three decades of experience, Blumenthal serves as CEO for Florida Funders where he is also an investor-member and serves on the company’s Board of Managers.
Valerie Landrio McDevitt is an Associate Vice President at the University of South Florida, representing the university in matters related to research and innovation, industry connections, startups, and technology transfer. Valerie oversees the Technology Transfer Office, Tampa Bay Technology Incubator, and the Student Innovation Incubator. Valerie received her BS in Chemistry from Siena College, MST in Chemistry at the University of Florida, and a JD at Emory University School of Law.
Samuel A. Wickline, M.D. is the Director of the USF Health Heart Institute, TGH Professor of Cardiovascular Medicine, and Associate Dean for Cardiovascular Research. Dr. Wickline moved to USF in December 2016 from Washington University School of Medicine, where he was a founding member of several academic initiatives. He has been an Established Investigator of the American Heart Association, a member of the American Society for Clinical Investigation, and recipient of a number of awards for teaching, entrepreneurship, and academics at Washington University. Dr. Wickline has authored over 300 research papers, holds more than 50 patents, and founded four biotech startup companies pursuing the development of personalized nanomedicines and medical diagnostic imaging devices.